In a study of approximately 386,000 women published in JAMA Network Open, almost half of those who took antidepressants ...

Perspective from Mary Jane Minkin, MD, FACOG Postmenopausal women with vulvovaginal atrophy treated with intravaginal prasterone for at least 12 weeks were nearly 50% less likely to develop a ...

For topical use only; not for oral, ophthalmic, or intravaginal use. Do not use more gel than necessary to cover the treatment area; may increase skin irritation. For topical use only; not for ...